Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

The U.S. Food and Drug Administration on Friday approved a new ​formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ‌scanning access through increased production ...

Dr Fred Saad of the University of Montreal discusses the future direction of alpha emitter agents in the treatment of prostate cancer, emphasizing the logical progression of resea ...

Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...